Conversations with CEI

Conversations with CEI

By Clinical Education InitiativeScienceMedicineHealth & FitnessEducationCoursesLife Sciences
Download on the App Store

Conversations with CEI episodes

  • Insights from the 13th International AIDS Society Conference on HIV Science

    In this episode of Conversations with CEI, Dr. Steven Fine unpacks some of the latest developments and research presented at the 2025 International AIDS Society (IAS) Conference on HIV Science, held in Kigali, Rwanda. From innovative treatment strategies to advancements in prevention and global health equity, Dr. Fine highlights the pivotal discussions and groundbreaking studies that are shaping the future of HIV care. Tune in to gain a deeper understanding of the strides being made in the fight against HIV and the collaborative efforts driving progress on a global scale. Related Content: 

    • The International AIDS Society (IAS) https://www.iasociety.org/conferences/ias2025 Official site for the IAS 2025, 13th IAS Conference on HIV Science, held in Kigali, Rwanda, from July 14-17, 2025.
    • https://www.iasociety.org/blog/takeaways-ias-2025 Takaways from the IAS 2025 Conference

    • CEI Clinical Consultation Line 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health.

    • www.ceitraining.org

      17 min
    • Evolving Landscape of Geriatric HIV Care
      The demographics of HIV care are rapidly changing, and with them, the clinical needs of patients aging with HIV. In this episode, host Dr. Tony Urbina, Medical Director for CEI's HIV Primary Care and Prevention Center of Excellence, sits down with geriatrician Dr. Angela Condo to explore the unique intersection of geriatric medicine and HIV care.
       
      Dr. Angela Condo is a board-certified internist and geriatrician at Mount Sinai's Icahn School of Medicine, where she established the Comprehensive Program of Integrated Care for Older Adults with HIV at the Peter Krueger Clinic. With initial support from the Keith Herring Foundation and additional HRSA funding through the Aging with HIV initiative, her interdisciplinary program has been serving patients for five years using an innovative embedded consultation model. Related Content: 
      • NYS DOH AI Guidance on Addressing the Needs of Older Patients in HIV Care: https://www.hivguidelines.org/guideline/hiv-aging/

      • CEI Clinical Consultation Line

        1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health.

      • ceitraining.org

        28 min
      • Highlights and Perspectives from the 11th Annual NYS Sexual Health Conference

        Live from Canandaigua…it’s the 11th Annual NYS Sexual Health Conference!

        The CEI Sexual Health Center of Excellence hosted the 11th Annual NYS Sexual Health Conference in-person on Friday May 2, 2025, in beautiful Canandaigua, NY. This was the Center’s second in-person conference since the COVID-19 pandemic and was the Center’s largest in-person event held to-date, bringing together over 225 clinicians and public health professionals from across NYS (and beyond!). 

        In this episode, host Juhua Wu, Director of the University of Rochester Center for Community Practice and team member of the CEI Sexual Health Center of Excellence, checks in live from the conference with four presenters about their experience at the conference, perspectives on what they learned from other sessions, and “need to know” highlights from their own presentations. Join Juhua, along with Rachel Hart-Malloy, PhD, MPH, Brenda Tesini, MD, Michael Brennan, DNP, FNP, and Jeremy Kidd, MD, MPH, for a real-time review of the conference! Related Content:

        • STI Dashboard New York: https://www.stidashboardny.org/  
        • Chemsex: Questions and Answers: https://www.suguidelinesnys.org/guideline/chemsex/ 
        • New York State Department of Health, Healthy Sex campaign: https://campaigns.health.ny.gov/SexualHealth 
        • University of Rochester Center for Community Practice: www.urccp.org 
        • CEI Clinical Consultation Line
          • 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health.
        • ceitraining.org
          • 17 min
        • Xylazine & Medetomidine & Nitazines, Oh My! An Update on New York State’s Drug Supply

          New York drug overdose deaths and death rates are on the decline, but with significant disparities and the current, toxic drug supply is partially to blame. Harmful additives like fentanyl analogues, xylazine and medetomidine, among others, have been found in cocaine, heroin, MDMA and pressed into pills. Additives are undetectable by sight, taste and smell which increases the risk of overdose for people who use and may not be aware of what’s in their drug supply.

          This episode features Drs. Sharon Stancliff and Jennifer Love discussing additives commonly found in the New York State supply, including BTMPS, fentanyl analogues, medetomidine, nitazenes and an updates on xylazine. Related Content: 

          • New York State Department of Health AIDS Institute Clinical Guidelines Program for Substance Use Care: https://www.suguidelinesnys.org/
          • New York State Department of Health Drug Checking Program: https://www.health.ny.gov/diseases/aids/consumers/prevention/oduh/drug_checking.htm
          • New York City Department of Health Drug Checking Program: https://www.nyc.gov/site/doh/health/health-topics/alcohol-and-drug-use-services.page
          • New York City Department of Health. Setting Up a Drug-checking Program: A Comprehensive Guide to Implementation. https://www.nyc.gov/assets/doh/downloads/pdf/basas/drug-checking-program-implementation-guide.pdf
          • https://legislativeanalysis.org/wp-content/uploads/2025/03/BTMPS-Fact-Sheet-FINAL.pdf
          • Friedman, JR, et al. (2025) The detection of xylazine in Tijuana, Mexico: Triangulating drug checking and clinical urine testing data. J Addict Med. doi: 10.1097/ADM.0000000000001474
          • Krotulski, AJ, et al. (2024) Medetomidine Rapidly Proliferating Across USA — Implicated In Recreational Opioid Drug Supply & Causing Overdose Outbreaks, Center for Forensic Science Research and Education, United States. Available from https://www.cfsre.org/images/content/reports/public_alerts/Public_Alert_Medetomidine_052024.pdf
          • New York Medication for Addiction Treatment and Electronic Referrals (MATTERS) Program. Request test strips (for xylazine and fentanyl). Available from: https://mattersnetwork.org/request-test-strips/
          • New York State Office of Addiction Services and Supports (OASAS). Harm Reduction Delivered (online order for xylazine and fentanyl test strips). Available from: https://oasas.ny.gov/harm-reduction-delivered
          • NEXT Distro. Ordering Supplies (for safer drug use). Available from: https://nextdistro.org/nydistro 
          • CEI Clinical Consultation Line
            • 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health.
          • ceitraining.org
            • 30 min
          • CEI…we got you! Evolving with the Science

            In this episode of Conversations with CEI, we engage with CEI’s clinicians, researchers, and public health experts to explore current and emerging issues in HIV primary care, sexual health, Hepatitis C, and drug user health.

            From the early days of the HIV epidemic to today’s complex syndemic approach, our experts share valuable insights and practical strategies for translating science into practice.

            We emphasize the importance of a syndemic approach to care, recognizing the overlapping health needs of patients, particularly in the marginalized population. Through a wide range of training and resources, CEI supports New York State clinicians in delivering comprehensive and inclusive care. Related Content:

            • CEI Clinical Consultation Line
              • 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health.
              • ceitraining.org
                • 39 min
              • Navigating Measles Vaccine Recommendations for Patients with HIV

                In light of the increase in measles cases within the United States, this episode features Dr. Steven Fine, an infectious disease expert, who offers a comprehensive exploration of the history and progress of measles eradication efforts. Dr. Fine delves into the factors contributing to the resurgence of measles, particularly the role of misinformation in undermining public trust and vaccination efforts. Additionally, Dr. Fine walks us through the latest vaccination recommendations for patients with HIV, addressing the unique considerations required to safeguard this vulnerable group. Tune in to gain valuable insights and practical guidance on current vaccination recommendations aimed at protecting patients with HIV from measles in today's healthcare environment. Related Content:

                • Measles for Health Care Providers: https://www.health.ny.gov/diseases/communicable/measles/providers/
                  • Measles Cases and Outbreaks | Measles (Rubeola) | CDC https://www.cdc.gov/measles/data-research/index.html
                    • CEI Clinical Consultation Line
                      • 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health.
                      • ceitraining.org
                        • 21 min
                      • The Invisible Latino HIV Crisis

                        In May 2024, the Centers for Disease Control and Prevention (CDC) released its annual HIV surveillance reports. The new data show a continuation of year-over-year reductions through 2022 in the estimated number of new HIV infections in the United States. But disconcerting trends among Latino people — the country’s second-largest racial or ethnic group after White, non-Latino people — reflect persistent failures in HIV prevention and treatment systems that this overall progress has overshadowed. Related Content: 

                        • CEI Line: 1-866-637-2342
                        • ceitraining.org
                          • 22 min
                        • Updates in Syphilis: Looking Back to Look Forward

                          Let’s dive in!

                          This month, we welcome new hosts Patrick Passarelli, MD, an infectious diseases fellow at the University of Rochester, and Nicholas Gerbino, a public health professional at the Monroe County Sexual Health Clinic, who take a deep dive into all things syphilis. Dr. Passarelli and Nick discuss history, epidemiological trends, updates and diagnostics, screening strategies, and new studies exploring additional treatment and preventative options for syphilis. Related Content:

                          • CDC’s Sexually Transmitted Infections Surveillance, 2023: https://www.cdc.gov/sti-statistics/annual/index.html
                          • The Resurgence of Congenital Syphilis in NYS: A Look at the Past and Present to Change the Future: https://cei.podbean.com/e/the-resurgence-of-congenital-syphilis-in-nys-a-look-at-the-past-and-present-to-change-the-future/
                          • Reflections from the 2024 CDC STI Prevention Conference: https://cei.podbean.com/e/reflections-from-the-2024-cdc-sti-prevention-conference/
                          • CEI Line: 1-866-637-2342
                          • ceitraining.org
                            • 35 min
                          • The Role of Opioid Treatment Programs in Hepatitis C Care: A Path to Elimination

                            Between 2010 and 2022 (the latest year for which data are available), 194,375 New Yorkers were diagnosed with hepatitis C (HCV) and of those, 53% (103,213 individuals) are known to have cleared their infection either through treatment or spontaneously. This statistic is worth celebrating, but also highlights the ongoing need for action – the goal outlined in New York State’s Hepatitis C Elimination Plan is to reach 80% by 2030. Furthermore, people who inject drugs are disproportionally affected by HCV – in 2022, 48% of newly reported cases of acute HCV in New York indicated injection drug use as a risk factor. And, when analyzing cases with known risk factors, that figure rose to 81% of newly reported acute cases indicating injection drug use. Providing HCV treatment in opioid treatment program (OTP)s is an innovative and necessary strategy to curb the ongoing epidemic and achieve statewide goals for elimination.

                            This episode features Abigail Hunter, MPH, MSN, FNP-BC, sharing her experience providing HCV treatment at an OTP and recommendations for listeners interested in integrating treatment into clinical services.  Related Content:

                            • CEI Training “Hepatitis C and Injection Drug Use” - https://ceitraining.org/courses/1148
                            • VOCAL-NY: https://www.vocal-ny.org/
                            • Respectful, Equitable Access to Comprehensive Healthcare (REACH) Program at Mount Sinai: https://www.mountsinai.org/care/primary-care/upper-east-side/ima/reach
                            • New York State Department of Health AIDS Institute guideline for the treatment of chronic hepatitis C virus infection in Adults: https://www.hivguidelines.org/hepatitis-care/hcv-treatment/
                            • Taylor, LE. (2020), Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics. Clinical Liver Disease, 16:12-15. https://doi.org/10.1002/cld.921
                            • Addiction Technology Transfer Center Guide to Integrating HCV Services into Opioid Treatment Programs: https://attcnetwork.org/sites/default/files/2020-07/Guide%20to%20Integrating%20HCV%20Services%20into%20Opioid%20Treatment%20-%20July%2024-1.pdf
                            • New York State Hepatitis C Elimination Plan: https://www.health.ny.gov/diseases/communicable/hepatitis/hepatitis_c/docs/hepatitis_c_elimination_plan.pdf
                            • New York State Hepatitis C Dashboard: https://hcvdashboardny.org/ 

                            • CEI toll free line for NYS providers: 866-637-2342

                            • https://ceitraining.org/

                            •  
                              • 21 min
                            • Use of Injectable Cabotegravir for HIV PrEP in Pregnancy

                              This podcast outlines some of the data presented at the 25th International AIDS Conference from HPTN 084 as it pertains to using injectable cabotegravir for HIV PrEP during pregnancy. Related Content: 

                              • https://www.hptn.org/research/studies/hptn-084

                              • https://programme.aids2024.org/Programme/Session/349

                              • CEI toll free line for NYS providers: 866-637-2342

                              • https://ceitraining.org/
                                • 10 min

                              About Conversations with CEI

                              From the publisher's feed

                              Conversations with Clinical Education Initiative (CEI) features clinical experts in HIV Primary Care and Prevention, Sexual Health, Hepatitis C and Drug User Health. Our episodes feature CEI…